Ignite Creation Date:
2024-05-06 @ 1:39 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04087473
Status:
RECRUITING
Last Update Posted:
2024-02-01
First Post:
2019-09-09
Brief Title:
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
Sponsor:
National Cancer Centre Singapore
Organization:
National Cancer Centre Singapore
Conditions & Keywords Data
Conditions:
| Name |
|---|
| ALK-Positive Lung Cancer |
| Non-small Cell Lung Cancer |
Keywords:
| Name | View |
|---|---|
| ALK inhibitor ALKi | View |
| NSCLC | View |
| Anaplastic lymphoma kinase ALK fusion oncogene NSCLC | View |
| Guardant360 assay | View |
| Next-Generation Sequencing NGS DNA sequencing test | View |
| Cell-free circulating tumor DNA ctDNA | View |
| Plasma profiling | View |
| Blood-based assay | View |
| Mutational testing | View |
| 74 genetic alterations point mutations copy number variants fusions insertions deletions | View |
| ALK resistance mutations | View |